The EBDC is a two-day meeting that aims to bring a selected group of 120 business development executives from international pharmaceutical corporations and European biotech companies together with representatives from private equity and venture capital companies.
As always we will offer a sophisticated line-up of international speakers in four sessions focusing on the newest trends in therapeutic development. The EBCD program also includes company presentations from innovative biotechs and of course provides conference partnering again.
This content is blocked. Accept cookies to view the content.